The present invention relates to an inhibitor of CT-1 polypeptide for reducing or eliminating autophagy of fibroblasts in an inflammatory disease. The invention also discloses a method of treating a patient by administering a CT-1 inhibitor, a method of reducing stroma supported tumor growth and an in vitro method for detecting and monitoring tumor growth.